More like this
- 'Lone wolf' FDA investigator says 'clinical trial system is broken'
- Avandia tale shows weaknesses in regulatory system
- Another reason to follow the money: the globalization of mental illness
- Release of 'Bad Pharma' in U.S. may help spur clinical-trial reforms
- Advair misused: Article describes troubling details of the overselling of an asthma drug